MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328AA8. A total of 16 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,730,000 | -29.6% | 2,015,000 | -28.4% | 0.00% | -100.0% |
| Q2 2017 | $2,458,000 | +3.5% | 2,815,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $2,376,000 | -12.1% | 2,815,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $2,704,000 | -65.9% | 2,815,000 | -56.9% | 0.00% | -50.0% |
| Q3 2016 | $7,928,000 | +5.0% | 6,524,000 | -8.4% | 0.00% | 0.0% |
| Q2 2016 | $7,547,000 | -21.1% | 7,120,000 | +11.2% | 0.00% | 0.0% |
| Q1 2016 | $9,568,000 | +1.7% | 6,400,000 | -2.3% | 0.00% | 0.0% |
| Q4 2015 | $9,407,000 | -10.3% | 6,550,000 | -0.8% | 0.00% | -33.3% |
| Q3 2015 | $10,484,000 | +45.7% | 6,601,000 | +92.3% | 0.00% | +50.0% |
| Q2 2015 | $7,194,000 | -18.9% | 3,432,000 | -23.7% | 0.00% | 0.0% |
| Q1 2015 | $8,876,000 | -12.0% | 4,500,000 | -14.9% | 0.00% | 0.0% |
| Q4 2014 | $10,087,000 | +10.0% | 5,290,000 | -10.4% | 0.00% | 0.0% |
| Q3 2014 | $9,174,000 | +30.2% | 5,902,000 | +10.9% | 0.00% | 0.0% |
| Q2 2014 | $7,045,000 | +39.3% | 5,322,000 | +6.4% | 0.00% | +100.0% |
| Q1 2014 | $5,056,000 | +3.1% | 5,000,000 | +5.2% | 0.00% | 0.0% |
| Q4 2013 | $4,906,000 | +36.1% | 4,752,000 | +19.3% | 0.00% | 0.0% |
| Q3 2013 | $3,605,000 | – | 3,983,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|